Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT04617522 |
Title | Study to Determine an Appropriate Starting Dose of Sacituzumab Govitecan-hziy in Participants With Advanced or Metastatic Solid Tumor and Moderate Liver Impairment |
Recruitment | Recruiting |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | Gilead Sciences |
Indications | |
Therapies | |
Age Groups: | senior | adult |
Covered Countries | USA | FRA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Pacific Shores Medical Group | SUSPENDED | Long Beach | California | 90813 | United States | Details |
Christiana Care Health Services | RECRUITING | Newark | Delaware | 19713 | United States | Details |
University of Maryland | RECRUITING | Baltimore | Maryland | 21201 | United States | Details |
NEXT Austin | WITHDRAWN | Austin | Texas | 78758 | United States | Details |
Oncology Consultants, P.A. | RECRUITING | Houston | Texas | 77030 | United States | Details |
The University of Texas M.D. Anderson Cancer Center | RECRUITING | Houston | Texas | 77030 | United States | Details |
NEXT Oncology | RECRUITING | San Antonio | Texas | 78229 | United States | Details |
Institut Bergonie Medical Oncology | RECRUITING | Bordeaux | 33000 | France | Details | |
Centre Leon Berard | RECRUITING | Lyon | 69373 | France | Details |